Suppr超能文献

[DNA倍体作为子宫颈癌预后因素的研究]

[The study of DNA ploidy as a prognostic factor in uterine cervical cancer].

作者信息

Watanabe Y, Ikeda M

机构信息

Department of Obstetrics and Gynecology, Kinki University School of Medicine, Osaka.

出版信息

Nihon Sanka Fujinka Gakkai Zasshi. 1992 Sep;44(9):1127-34.

PMID:1453042
Abstract

Nuclear DNA content was measured in 410 paraffin-embedded samples from 136 cases (43 stage Ib and 93 stage IIb) of uterine cervical cancer by flow cytometry, and the significance of DNA ploidy for use as a prognostic factor was evaluated. Positive parametrial invasion cases (p less than 0.05), metastasis to pelvic lymph nodes cases and lymphatic vessel permeation form (p less than 0.05) showed a high incidence of DNA aneuploidy. In the study of the relationship between DNA ploidy and prognosis by the Kaplan-Meier method, the DNA aneuploid group showed a tendency to a poor prognosis in all cases, large cell non-keratinizing cases (p less than 0.05), and large cell non-keratinizing pT2b with pelvic lymph nodes metastasis cases (p less than 0.05), and the DNA aneuploid group had significantly lower three- and five-year survival rates (p less than 0.05).

摘要

通过流式细胞术对136例子宫颈癌(43例Ib期和93例IIb期)的410份石蜡包埋样本进行了核DNA含量测定,并评估了DNA倍性作为预后因素的意义。阳性宫旁浸润病例(p<0.05)、盆腔淋巴结转移病例和淋巴管浸润型(p<0.05)显示DNA非整倍体的发生率较高。在通过Kaplan-Meier法研究DNA倍性与预后的关系时,DNA非整倍体组在所有病例、大细胞非角化病例(p<0.05)以及伴有盆腔淋巴结转移的大细胞非角化pT2b病例(p<0.05)中均显示出预后不良的趋势,且DNA非整倍体组的3年和5年生存率显著较低(p<0.05)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验